Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Neriman Gokden

Concepts (349)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Kidney Neoplasms
13
2021
174
2.560
 Why?
Carcinoma, Renal Cell
13
2021
101
2.220
 Why?
Kidney Diseases
8
2020
213
1.140
 Why?
Immunohistochemistry
14
2021
955
1.100
 Why?
PAX2 Transcription Factor
4
2010
22
1.030
 Why?
Kidney
14
2025
690
1.020
 Why?
Kidney Tubules
7
2021
61
1.000
 Why?
Immunoglobulin Light Chains
4
2017
83
0.780
 Why?
Neoplasms, Complex and Mixed
1
2020
2
0.700
 Why?
Rhabdoid Tumor
1
2020
11
0.690
 Why?
Stromal Cells
1
2020
75
0.670
 Why?
Soft Tissue Neoplasms
1
2020
54
0.650
 Why?
Acute Kidney Injury
8
2025
302
0.640
 Why?
Immune Complex Diseases
2
2008
6
0.570
 Why?
Sepsis
7
2014
225
0.540
 Why?
Mitogen-Activated Protein Kinases
2
2008
154
0.490
 Why?
Adenoma
2
2021
113
0.430
 Why?
Adenoma, Oxyphilic
2
2010
11
0.420
 Why?
Carcinoma, Papillary
2
2010
47
0.410
 Why?
Male
38
2025
25866
0.400
 Why?
Middle Aged
26
2025
12579
0.380
 Why?
Renal Circulation
5
2013
56
0.370
 Why?
Prostatic Neoplasms
5
2010
386
0.370
 Why?
Humans
44
2025
50419
0.360
 Why?
Proteinuria
2
2010
37
0.360
 Why?
Glomerulonephritis, IGA
1
2010
5
0.350
 Why?
Podocytes
1
2010
19
0.350
 Why?
Microcirculation
5
2014
64
0.340
 Why?
Nephrectomy
2
2010
78
0.340
 Why?
Antigens, Neoplasm
2
2008
148
0.330
 Why?
Microscopy, Electron, Transmission
5
2014
73
0.330
 Why?
Neurofibromatosis 2
1
2009
8
0.320
 Why?
Adult
19
2023
13561
0.300
 Why?
DNA Glycosylases
1
2008
19
0.300
 Why?
Lymph Nodes
1
2010
256
0.290
 Why?
Renal Insufficiency
4
2013
109
0.290
 Why?
Kidney Glomerulus
1
2008
37
0.290
 Why?
Plasmacytoma
2
2020
42
0.290
 Why?
Female
25
2025
27053
0.280
 Why?
DNA Repair
1
2008
187
0.270
 Why?
Diagnosis, Differential
6
2021
1029
0.270
 Why?
Hypercalcemia
1
2007
33
0.270
 Why?
Alphapapillomavirus
1
2006
13
0.270
 Why?
Sensitivity and Specificity
5
2011
855
0.260
 Why?
Predictive Value of Tests
6
2025
924
0.260
 Why?
Carcinoma
2
2020
137
0.260
 Why?
Bone Density Conservation Agents
1
2007
74
0.260
 Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2006
59
0.260
 Why?
Glomerulosclerosis, Focal Segmental
1
2006
13
0.260
 Why?
Urinary Bladder Neoplasms
3
2014
158
0.260
 Why?
Hepatitis B
1
2006
15
0.260
 Why?
Diphosphonates
1
2007
90
0.260
 Why?
Imidazoles
1
2007
125
0.260
 Why?
DNA, Viral
1
2006
134
0.260
 Why?
Prostatic Intraepithelial Neoplasia
2
2005
8
0.250
 Why?
Biopsy
6
2020
588
0.250
 Why?
Adenocarcinoma
2
2010
396
0.240
 Why?
Skin Neoplasms
2
2018
492
0.240
 Why?
Cisplatin
4
2025
283
0.240
 Why?
Insulin-Like Growth Factor Binding Protein 1
1
2025
15
0.240
 Why?
Neoplasms, Multiple Primary
1
2005
42
0.230
 Why?
Aged
14
2025
9738
0.230
 Why?
Paraproteinemias
2
2016
71
0.220
 Why?
Aged, 80 and over
8
2017
3233
0.210
 Why?
Pheochromocytoma
1
2023
36
0.210
 Why?
Adrenal Gland Neoplasms
1
2023
51
0.210
 Why?
Proteasome Endopeptidase Complex
1
2024
116
0.210
 Why?
Dermatofibrosarcoma
1
2003
8
0.210
 Why?
Oncogene Proteins, Fusion
1
2003
57
0.200
 Why?
Kidney Transplantation
1
2024
189
0.190
 Why?
Kidney Diseases, Cystic
1
2021
19
0.180
 Why?
Immunoglobulin G
2
2014
188
0.180
 Why?
Multiple Myeloma
3
2017
2990
0.180
 Why?
Precancerous Conditions
1
2021
83
0.170
 Why?
Carcinoma, Transitional Cell
2
2012
51
0.170
 Why?
Qb-SNARE Proteins
1
2019
6
0.170
 Why?
Antineoplastic Agents
3
2017
1165
0.170
 Why?
Qc-SNARE Proteins
1
2019
10
0.160
 Why?
Actin Cytoskeleton
1
2019
22
0.160
 Why?
Hepatic Stellate Cells
1
2019
17
0.160
 Why?
Neoplasms, Plasma Cell
1
2020
36
0.160
 Why?
Retrospective Studies
6
2025
6274
0.160
 Why?
Myofibroblasts
1
2019
49
0.160
 Why?
Kidney Failure, Chronic
1
2021
202
0.160
 Why?
Cell Nucleus
2
2010
183
0.150
 Why?
Neoplasm Metastasis
2
2010
230
0.150
 Why?
Mice
12
2025
5659
0.150
 Why?
Myoblasts
1
2018
18
0.150
 Why?
Melanoma
2
2018
278
0.140
 Why?
Animals
15
2025
13063
0.140
 Why?
Synovitis
1
2017
21
0.140
 Why?
Capillaries
4
2014
50
0.140
 Why?
Cell Proliferation
1
2021
980
0.140
 Why?
Eosinophilia
1
2017
35
0.140
 Why?
DNA, Neoplasm
3
2008
144
0.130
 Why?
Angiomyolipoma
1
2016
10
0.130
 Why?
Thoracic Neoplasms
1
2016
13
0.130
 Why?
Tuberous Sclerosis
1
2016
37
0.120
 Why?
Tumor Suppressor Proteins
1
2016
127
0.120
 Why?
Antibodies, Monoclonal, Humanized
1
2017
224
0.120
 Why?
Receptors, Lysosphingolipid
1
2014
5
0.120
 Why?
Reactive Nitrogen Species
3
2011
23
0.120
 Why?
Urothelium
1
2014
17
0.110
 Why?
Hemangiosarcoma
1
2014
15
0.110
 Why?
Mice, Inbred C57BL
6
2025
1796
0.110
 Why?
Neoplasm Staging
3
2014
738
0.110
 Why?
Immunoglobulin kappa-Chains
1
2014
20
0.110
 Why?
Necrosis
2
2012
173
0.110
 Why?
Glomerulonephritis, Membranous
1
2014
27
0.110
 Why?
Rolipram
1
2013
2
0.110
 Why?
Phosphodiesterase 4 Inhibitors
1
2013
3
0.110
 Why?
Molecular Targeted Therapy
1
2014
122
0.110
 Why?
Microscopy, Electron
2
2020
82
0.110
 Why?
Glomerular Filtration Rate
4
2017
119
0.110
 Why?
Translocation, Genetic
2
2005
236
0.110
 Why?
Organ Preservation
2
2024
30
0.100
 Why?
Sarcoidosis
1
2013
44
0.100
 Why?
Prospective Studies
2
2010
2378
0.100
 Why?
Livedo Reticularis
1
2012
5
0.100
 Why?
Cryoglobulinemia
1
2012
13
0.100
 Why?
Lipoprotein Lipase
1
2012
13
0.100
 Why?
DNA, Mitochondrial
2
2003
110
0.100
 Why?
Metalloporphyrins
1
2011
6
0.100
 Why?
Free Radical Scavengers
1
2011
24
0.100
 Why?
Cellular Microenvironment
1
2011
27
0.090
 Why?
Myocardium
2
2017
443
0.090
 Why?
Adrenal Cortex Neoplasms
1
2011
5
0.090
 Why?
Polymerase Chain Reaction
3
2008
447
0.090
 Why?
Triglycerides
1
2012
160
0.090
 Why?
Stilbenes
1
2011
52
0.090
 Why?
Tissue Array Analysis
2
2011
45
0.090
 Why?
Microscopy, Fluorescence
2
2014
160
0.090
 Why?
Disease Models, Animal
4
2025
1431
0.090
 Why?
Peritoneal Neoplasms
1
2012
63
0.090
 Why?
Metalloendopeptidases
1
2011
69
0.090
 Why?
Hematuria
1
2010
26
0.090
 Why?
Fluorescent Antibody Technique
1
2010
109
0.090
 Why?
Ejaculatory Ducts
1
2010
3
0.090
 Why?
Plasma Cells
1
2012
220
0.090
 Why?
Seminal Vesicles
1
2010
13
0.090
 Why?
RNA, Messenger
4
2012
1085
0.080
 Why?
Hemodynamics
1
2011
263
0.080
 Why?
Antioxidants
1
2011
237
0.080
 Why?
In Situ Hybridization
2
2006
66
0.080
 Why?
Prostate
1
2010
114
0.080
 Why?
Epithelial Cells
2
2011
203
0.080
 Why?
Lymphatic Metastasis
1
2010
221
0.080
 Why?
Fatal Outcome
1
2009
197
0.080
 Why?
Survival Analysis
3
2017
658
0.080
 Why?
Iron Chelating Agents
1
2008
11
0.080
 Why?
Ligation
3
2014
62
0.080
 Why?
Nephritis, Interstitial
1
2008
9
0.080
 Why?
Benzoates
1
2008
21
0.080
 Why?
Microsatellite Repeats
1
2008
37
0.070
 Why?
Glomerular Mesangium
1
2008
7
0.070
 Why?
Fluorescent Antibody Technique, Direct
1
2008
3
0.070
 Why?
Loss of Heterozygosity
1
2008
75
0.070
 Why?
Basement Membrane
1
2008
16
0.070
 Why?
Triazoles
1
2008
113
0.070
 Why?
Cell Membrane
1
2008
247
0.070
 Why?
Disease Progression
2
2025
825
0.070
 Why?
Glomerular Basement Membrane
1
2007
10
0.070
 Why?
Mutation
2
2003
1275
0.070
 Why?
Oxidative Stress
1
2011
770
0.070
 Why?
Kidney Pelvis
1
2006
16
0.070
 Why?
Prednisone
1
2007
101
0.070
 Why?
Paraffin Embedding
1
2006
51
0.070
 Why?
Karyotyping
3
2017
65
0.070
 Why?
Prognosis
2
2025
1974
0.060
 Why?
Heart Diseases
1
2009
213
0.060
 Why?
Young Adult
4
2021
4075
0.060
 Why?
Nephrotic Syndrome
1
2006
18
0.060
 Why?
Mice, Knockout
2
2025
840
0.060
 Why?
Clofibric Acid
1
2005
6
0.060
 Why?
Anti-Bacterial Agents
1
2011
751
0.060
 Why?
Lipopolysaccharides
1
2006
196
0.060
 Why?
Chromosomes, Human, Pair 2
1
2005
21
0.060
 Why?
Chromosomes, Human, Pair 7
1
2005
29
0.060
 Why?
Chromosomes, Human, Pair 9
1
2005
13
0.060
 Why?
Chromosomes, Human, Pair 5
1
2005
15
0.060
 Why?
Neurofibroma
1
2005
16
0.060
 Why?
Glucocorticoids
1
2007
233
0.060
 Why?
Foot
1
2005
40
0.060
 Why?
Fibroma
1
2005
39
0.060
 Why?
Blood Pressure
3
2011
525
0.060
 Why?
Protein Synthesis Inhibitors
1
2004
17
0.060
 Why?
Biopsy, Needle
1
2005
179
0.060
 Why?
Endodeoxyribonucleases
1
2004
44
0.060
 Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2005
120
0.050
 Why?
Adrenalectomy
1
2023
34
0.050
 Why?
Adrenal Glands
1
2023
39
0.050
 Why?
Gene Expression Regulation, Enzymologic
1
2004
178
0.050
 Why?
Vulva
1
2003
17
0.050
 Why?
Groin
1
2003
16
0.050
 Why?
RNA, Neoplasm
1
2003
44
0.050
 Why?
Proteasome Inhibitors
1
2024
104
0.050
 Why?
Time Factors
3
2014
2933
0.050
 Why?
Micromanipulation
1
2002
2
0.050
 Why?
Cytoplasm
1
2003
92
0.050
 Why?
Immunoenzyme Techniques
1
2003
140
0.050
 Why?
Biopsy, Fine-Needle
1
2003
108
0.050
 Why?
Blotting, Western
3
2012
575
0.050
 Why?
Rats
2
2024
3262
0.050
 Why?
Perfusion
1
2002
45
0.050
 Why?
Sodium Chloride
1
2002
56
0.050
 Why?
Sequence Analysis, DNA
1
2003
194
0.050
 Why?
Neoplasm Invasiveness
2
2014
269
0.050
 Why?
Blood Flow Velocity
2
2013
99
0.050
 Why?
Hypothermia, Induced
1
2002
39
0.050
 Why?
Mass Screening
1
2005
343
0.050
 Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2011
568
0.050
 Why?
Severity of Illness Index
1
2025
976
0.050
 Why?
Cardiac Surgical Procedures
1
2025
314
0.050
 Why?
Capillary Permeability
2
2011
26
0.050
 Why?
Adolescent
3
2014
6453
0.050
 Why?
Bone Neoplasms
1
2003
178
0.040
 Why?
Hyperplasia
1
2021
97
0.040
 Why?
Transcription Factors
1
2004
561
0.040
 Why?
Cell Differentiation
2
2014
640
0.040
 Why?
Liver
2
2019
1126
0.040
 Why?
Clinical Laboratory Techniques
1
2020
28
0.040
 Why?
In Situ Hybridization, Fluorescence
1
2021
231
0.040
 Why?
Heart Rate
2
2011
304
0.040
 Why?
Stress Fibers
1
2019
5
0.040
 Why?
Actin Depolymerizing Factors
1
2019
5
0.040
 Why?
Treatment Outcome
3
2017
5265
0.040
 Why?
rho-Associated Kinases
1
2019
19
0.040
 Why?
RNA, Viral
1
2020
107
0.040
 Why?
Carbon Tetrachloride
1
2019
22
0.040
 Why?
Gene Knockdown Techniques
1
2019
104
0.040
 Why?
Child, Preschool
2
2011
3953
0.040
 Why?
Cell Separation
1
2019
92
0.040
 Why?
Liver Neoplasms
1
2003
321
0.040
 Why?
Nitrites
2
2011
32
0.040
 Why?
Nitrates
2
2011
30
0.040
 Why?
Actins
1
2019
112
0.040
 Why?
Antibodies, Monoclonal
1
2003
460
0.040
 Why?
Neutrophil Infiltration
2
2012
24
0.040
 Why?
RNA, Small Interfering
1
2019
208
0.040
 Why?
RNA Interference
1
2019
179
0.040
 Why?
Cecum
2
2011
59
0.040
 Why?
Cell Movement
1
2019
244
0.040
 Why?
Wound Healing
1
2019
183
0.040
 Why?
Cell Dedifferentiation
1
2018
9
0.040
 Why?
Reactive Oxygen Species
2
2011
408
0.040
 Why?
Kidney Function Tests
1
2017
52
0.030
 Why?
Lung Neoplasms
1
2003
597
0.030
 Why?
Liver Cirrhosis
1
2019
227
0.030
 Why?
Microscopy, Video
2
2007
13
0.030
 Why?
Cell Line
1
2019
997
0.030
 Why?
Nitric Oxide Synthase Type II
2
2007
63
0.030
 Why?
Acute Disease
2
2008
374
0.030
 Why?
Risk Factors
1
2005
3712
0.030
 Why?
Cardiomyopathy, Restrictive
1
2016
5
0.030
 Why?
Genomics
1
2017
238
0.030
 Why?
Cysts
1
2016
50
0.030
 Why?
Bone Marrow
1
2017
360
0.030
 Why?
Immunotherapy
1
2017
234
0.030
 Why?
Oxadiazoles
1
2014
10
0.030
 Why?
Permeability
1
2014
65
0.030
 Why?
Punctures
1
2014
52
0.030
 Why?
Thiophenes
1
2014
36
0.030
 Why?
Antigen-Antibody Complex
1
2014
35
0.030
 Why?
Terminology as Topic
1
2014
67
0.030
 Why?
Pyrazoles
1
2014
111
0.030
 Why?
Angiotensin-Converting Enzyme Inhibitors
1
2014
74
0.030
 Why?
Pyridines
1
2014
130
0.030
 Why?
Granuloma
1
2013
45
0.030
 Why?
Signal Transduction
1
2019
1608
0.030
 Why?
Bone Marrow Examination
1
2012
11
0.020
 Why?
Receptors, Lipoprotein
1
2012
7
0.020
 Why?
Azo Compounds
1
2012
10
0.020
 Why?
Angiopoietins
1
2012
5
0.020
 Why?
Peroxisome Proliferator-Activated Receptors
1
2012
14
0.020
 Why?
Plasma Exchange
1
2012
25
0.020
 Why?
Coloring Agents
1
2012
67
0.020
 Why?
Immunosuppressive Agents
1
2014
227
0.020
 Why?
Adipose Tissue, White
1
2012
34
0.020
 Why?
Epithelium
1
2011
66
0.020
 Why?
Cystectomy
1
2012
49
0.020
 Why?
Cell Hypoxia
1
2011
82
0.020
 Why?
Child
2
2016
6931
0.020
 Why?
Superoxide Dismutase
1
2011
114
0.020
 Why?
Telemetry
1
2011
28
0.020
 Why?
Peritonitis
1
2011
24
0.020
 Why?
Dose-Response Relationship, Drug
1
2014
1369
0.020
 Why?
Multiple Organ Failure
1
2011
48
0.020
 Why?
Vasodilator Agents
1
2011
96
0.020
 Why?
Hydroxamic Acids
1
2011
37
0.020
 Why?
Hypothermia
1
2011
36
0.020
 Why?
Fluid Therapy
1
2011
73
0.020
 Why?
Oxidation-Reduction
1
2011
313
0.020
 Why?
Interleukin-1beta
1
2011
72
0.020
 Why?
United States
1
2021
5005
0.020
 Why?
Body Weight
1
2012
517
0.020
 Why?
Animals, Newborn
1
2011
361
0.020
 Why?
Membrane Proteins
1
2012
337
0.020
 Why?
Gene Expression
1
2012
605
0.020
 Why?
Skin
1
2012
382
0.020
 Why?
Infant, Newborn
1
2016
2752
0.020
 Why?
Iron Overload
1
2008
8
0.020
 Why?
Cells, Cultured
1
2012
1563
0.020
 Why?
Erythrocyte Transfusion
1
2008
52
0.020
 Why?
Eosinophils
1
2008
40
0.020
 Why?
Drug Hypersensitivity
1
2008
38
0.020
 Why?
Myelodysplastic Syndromes
1
2008
78
0.020
 Why?
Rats, Sprague-Dawley
1
2011
1556
0.020
 Why?
NADP
1
2006
22
0.020
 Why?
Blood Urea Nitrogen
1
2006
39
0.020
 Why?
Lysine
1
2007
84
0.020
 Why?
Creatinine
1
2006
142
0.020
 Why?
Nuclease Protection Assays
1
2005
2
0.020
 Why?
Stress, Physiological
1
2006
171
0.020
 Why?
Receptors, CCR5
1
2005
6
0.020
 Why?
Receptors, CCR1
1
2005
10
0.020
 Why?
Chemokine CCL5
1
2005
9
0.020
 Why?
Receptors, Chemokine
1
2005
13
0.020
 Why?
Nitric Oxide
1
2007
253
0.010
 Why?
Vascular Cell Adhesion Molecule-1
1
2005
37
0.010
 Why?
Electrophoretic Mobility Shift Assay
1
2005
71
0.010
 Why?
Intercellular Adhesion Molecule-1
1
2005
61
0.010
 Why?
Enzyme Inhibitors
1
2007
369
0.010
 Why?
Muscle Neoplasms
1
2005
16
0.010
 Why?
Chemokines
1
2005
75
0.010
 Why?
PPAR alpha
1
2005
56
0.010
 Why?
Prostatectomy
1
2005
82
0.010
 Why?
Enzyme-Linked Immunosorbent Assay
1
2005
227
0.010
 Why?
Chromosome Mapping
1
2005
143
0.010
 Why?
Kidney Tubules, Proximal
1
2004
61
0.010
 Why?
Receptors, Cytoplasmic and Nuclear
1
2004
66
0.010
 Why?
Ligands
1
2004
203
0.010
 Why?
Pyrimidines
1
2005
187
0.010
 Why?
Cell Death
1
2004
175
0.010
 Why?
Antigens, CD
1
2005
221
0.010
 Why?
NF-kappa B
1
2005
306
0.010
 Why?
Tumor Necrosis Factor-alpha
1
2005
386
0.010
 Why?
Models, Genetic
1
2003
166
0.010
 Why?
Multigene Family
1
2002
46
0.010
 Why?
Infant
1
2011
3648
0.010
 Why?
Renal Artery Obstruction
1
2002
22
0.010
 Why?
Lasers
1
2002
106
0.010
 Why?
Base Sequence
1
2003
622
0.010
 Why?
Polymorphism, Genetic
1
2002
177
0.010
 Why?
Cytokines
1
2005
602
0.010
 Why?
Models, Animal
1
2002
225
0.010
 Why?
Ischemia
1
2002
145
0.010
 Why?
Swine
1
2002
408
0.010
 Why?
Feasibility Studies
1
2002
389
0.010
 Why?
Laparoscopy
1
2002
172
0.010
 Why?
Gokden's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (349) concept(s)
_
Co-Authors Expand Description
See all (45) people
_
Similar People Expand Description
See all (32) people
_
Same Department Expand Description
Search Department